SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-024765
Filing Date
2020-09-09
Accepted
2020-09-09 16:51:46
Documents
1
Period of Report
2020-09-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3942
  Complete submission text file 0000899243-20-024765.txt   5349
Mailing Address C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801
Business Address
Esposito Pamela (Reporting) CIK: 0001744425 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 201166975

Mailing Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 2ND FLOOR CAMBRIDGE MA 02139 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences